NRG

NRG, based in Petten, is a leading company specializing in nuclear research and technological innovation. With over sixty years of experience in the nuclear sector, NRG is a global leader in producing medical isotopes for diagnostic and therapeutic applications, including over 30 million doses per year for cancer treatment. The company is also renowned for its pioneering research in nuclear energy, participating in international projects for the development of advanced reactor technologies, such as the High Temperature Reactor (HTR), enabling safe and sustainable energy generation.

Safety is paramount in all of NRG's endeavors. The company operates one of the world's most advanced research reactors, the High Flux Reactor (HFR), used for a wide range of research in nuclear science, medicine, and materials research.

With a team of over 700 highly qualified professionals, including scientists, engineers, and technicians, NRG continues to lead the nuclear sector through ongoing investments in research and development. The company aims to provide innovative solutions to the challenges of the 21st century in energy, healthcare, and the environment, contributing to a more sustainable and secure world for future generations.